Evaluation of the maternal-fetal transfer of granisetron in an ex vivo placenta perfusion model

Transplacental passage of granisetron was inconsistent at the 50 ng/mL concentration that achieved with IV dosing. However, there consistently was no detectable passage in all the placentas evaluated of the granisetron at 5 ng/mL concentration that would be achieved after transdermal patch administration.